| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -17.80M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TRVI returned +137.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +43.5% |
| 1 year | +137.9% |
| 5 years | +981.9% |
| All-time high | $18.65 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TRVI would be worth today ›No. Trevi Therapeutics, Inc. has not paid a dividend in the past 12 months.
Trevi Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TRVI.
Trevi Therapeutics, Inc. is part of the Healthcare sector.
Trevi Therapeutics, Inc. has a market cap of 2.56B USD, based on the latest quote.